Tag: Alzheimers

Signs of Alzheimer’s were everywhere. Then his brain improved

Editor’s note: CNN Chief Medical Correspondent Dr. Sanjay Gupta is a practicing neurosurgeon and best-selling author on brain health. “The Last Alzheimer’s Patient” premieres on “The Whole Story with Anderson Cooper” on Sunday, May 19, at 8 p.m. ET/PT on CNN and streams on MAX on June 18. Preventive neurologist Dr Richard Isaacson stared at the numbers on the […]

Woman claims Alzheimer’s symptoms were reversed after five years

In “The Last Alzheimer’s Patient,” CNN chief medical correspondent follows Alzheimer’s patient Cici Zerbe who says her symptoms have been reversed after participating in Dr. Dean Ornish’s clinical trial on the effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s Disease. That peer-reviewed study will be […]

Dr. Gupta discovers the results of an Alzheimer’s risk test

Facing concerns about his own family history of Alzheimer’s, CNN chief medical correspondent Dr. Sanjay Gupta visits preventive neurologist Dr. Richard Isaacson to have his own risk for dementia assessed in the CNN documentary “The Last Alzheimer’s Patient.” At the Institute for Neurodegenerative Diseases of Florida, Dr. Isaacson is leading a novel clinical trial focused […]

‘No truce yet’ in Gaza and Alzheimer’s treatment hope

Tuesday’s front pages are largely dominated by ceasefire negotiations in the ongoing Israel-Gaza war. The Times leads with Israel saying that no ceasefire has been agreed to, after Hamas said it had accepted a proposal brokered by Qatari and Egyptian mediators. [BBC] The Guardian leads on Israeli airstrikes starting in the southern Gazan city of […]

Biogen beats quarterly profit estimates, Alzheimer’s drug sales jump

(Reuters) -Biogen beat Wall Street estimates for first-quarter profit on Wednesday as a series of cost-cutting measures helped offset the impact of fierce competition for its older drugs, sending its shares up nearly 4% before the bell. The company also said its Alzheimer’s drug Leqembi, developed with Japanese partner Eisai, recorded global sales of about […]